You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Dementia: Neuropsychiatric Symptom Assessment

Percentage of patients, regardless of age, with a diagnosis of dementia and for whom an assessment of neuropsychiatric symptoms is performed and results reviewed at least once in a 12 month period

Date Reviewed: November 19, 2017

Measure Info

MIPS 283CMS 283
Measure Type: 
Process
Measure Steward: 
American Academy of Neurology
Clinical Topic Area: 
Dementia

Care Setting: 
Outpatient
Data Source: 
Registry

ACP does not support QPP measure 283: "Dementia: Neuropsychiatric Symptom Assessment." Although this practice may help clinicians determine appropriate management of patients with dementia, there is a lack of high-quality evidence examining the impact of assessment on clinical outcomes or on appropriate assessment intervals. Also, implementation may result in overuse of pharmacologic therapy. Non-pharmacologic treatment modalities exist to manage neuropsychiatric symptoms, but implementation requires caregiver involvement. Furthermore, the numerator details do not clearly specify a structured process for documentation of neuropsychiatric symptom assessment and the measure developers do not describe any reliability or validity data in the measure report.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!